Popular Herbal Supplement Does Not Appear to Improve Cholesterol Levels
According to the American Heart Association, about 40 million American adults have high cholesterol, or
Dietary supplements made of herbal extracts from
Researchers set out to investigate whether guggulipid could safely reduce cholesterol levels in healthy adults with
About the Study
The researchers randomized 103 adults to one of three groups: placebo, standard-dose guggulipid (SDG) of 1,000 milligrams (mg), and high-dose guggulipid (HDG) of 2,000 mg—taken three times daily with meals for eight weeks. Participants were told to maintain their usual dietary habits. The study was conducted from March 2000 through August 2001.
At the outset, participants were required to have an LDL of 130-200 mg/dL (3.37-5.18 mmol/L) and fasting triglyceride levels of less than 400 mg/dL (4.52 mmol/L). They were excluded if they had a history of cardiovascular disease, diabetes, untreated thyroid disorder, liver function abnormalities, or renal insufficiency.
Study assessments took place at baseline, four weeks, and eight weeks. At each visit, participants were weighed, had vital signs measured, were asked about adverse events and changes in medications, and had blood samples obtained for analysis.
Levels of LDL-cholesterol increased significantly by 4% in the SDG group and by 5% in the HDG group, while they decreased by 5% in the placebo group. There were no significant changes in levels of HDL-cholesterol (the “good” kind) or triglycerides. Additionally, no effect was seen on total cholesterol/HDL or LDL/HDL ratios. However, in those participants who had a high baseline level of LDL (160 mg/dL (4.14 mmol/L) or greater), there was a significant decrease of triglycerides in both guggulipid groups. And, small but non-significant decreases were seen in levels of other substances (lipoprotein a and c-reactive protein) thought to play a role in cardiovascular disease.
In terms of safety, guggulipid was generally well tolerated and did not appear to adversely affect the kidneys or liver. However, six participants developed a hypersensitivity drug rash associated with itching, which in five of the six cases, led to dropout from the study.
An important limitation of this study is that the researchers did not recommend a specific diet. Although there were no statistically significant changes in weight or dietary consumption of fat, cholesterol, or fiber among the participants by the end of the trial, it is possible that unforeseen aspects of participants’ diet influenced the results. In addition, patients who take other cholesterol-lowering medications and supplements in the real world are strongly advised to also lower their intake of cholesterol.
How Does This Affect You?
This study suggests that dietary supplements containing guggulipid do little to improve cholesterol levels and may even cause a hypersensitivity drug reaction in certain people. But the researchers also found a significant reduction of triglycerides in both the SDG and HDG groups among participants with high LDL-cholesterol levels, as well as borderline significant reductions in the level of other cardiovascular health markers. It could be that individuals with high triglycerides and LDL-cholesterol may benefit from supplementing their low-fat, high-fiber diet with guggulipid.
Because the study lasted only eight weeks, researchers could not assess whether guggulipid might improve or worsen a person’s chances of developing cardiovascular disease in the long-term, which is really the point. And, although the amount of guggulipid used in this study was relatively high, it is possible that higher doses are needed to have a clinically important effect.
While this study does not seem to support the use of guggulipid for the modification of lipids and other cardiovascular risk factors, it may be too soon to give up on this treatment. Meanwhile, try lowering your cholesterol by eating a healthful diet and getting plenty of exercise. If you have high blood cholesterol, talk to your doctor about what’s right for you.
Dietary Supplement Education Alliance
Office of Dietary Supplements
American Heart Association
National Heart, Lung, and Blood Institute
Szapary PO, Wolfe ML, Bloedon LT, Cucchiara AJ, DerMarderosian AH, Cirgliano MD, Rader DJ. Guggulipid for the treatment of hypercholesterolemia. JAMA . 2003;290(6):765-72.
Cholesterol Statistics. American Heart Association.
Available at: http://www.americanheart.org/presenter.jhtml?identifier=536
Accessed August 11, 2003.
High Blood Cholesterol: What You Need to Know. National Heart, Lung, and Blood Institute, National Institutes of Health (NIH).
Available at: http://www.nhlbi.nih.gov/health/public/heart/chol/wyntk.htm
Accessed August 12, 2003.
Last reviewed August 2003 by
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © 2007 EBSCO Publishing All rights reserved.